5DX — Meta Health Cashflow Statement
0.000.00%
Last trade - 00:00- SG$5.28m
- SG$6.98m
- SG$0.24m
Annual cashflow statement for Meta Health, fiscal year end - December 31st, SGD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | C2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -1.94 | 7.67 | -7.37 | -3.33 | -1.05 |
| Depreciation | |||||
| Non-Cash Items | 0.32 | -7.56 | 1.55 | -0.084 | 0.57 |
| Discontinued Operations | |||||
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.773 | -2.62 | 0.949 | -0.354 | -0.654 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 0.478 | 0.289 | -2.25 | -2.24 | -1.09 |
| Capital Expenditures | -0.394 | -0.315 | -0.494 | -0.414 | 0 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 4.9 | 3.5 | -1.76 | 5.11 | -1.6 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 4.51 | 3.19 | -2.25 | 4.7 | -1.6 |
| Financing Cash Flow Items | -0.432 | -0.45 | -0.821 | -0.394 | -0.141 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -3.02 | 2.48 | -2.3 | -0.284 | -2.29 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 2 | 5.97 | -6.94 | 1.95 | -4.98 |